VENUS PHARMA GMBH — Meropenem Importer Profile
Pharmaceutical Importer · #4 buyer for Meropenem · $3.0M import value · 162 shipments · GERMANY · DGFT Verified
VENUS PHARMA GMBH is the #4 importer of Meropenem from India with $3.0M in import value and 162 verified shipments. VENUS PHARMA GMBH holds a 4.4% market share in Meropenem imports based in GERMANY. The company sources from 1 verified supplier across 59 formulations shipped to 1 country.
VENUS PHARMA GMBH — Meropenem Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Meropenem to VENUS PHARMA GMBH?
Verified from 162 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| VENUS REMEDIES LIMITED | $3.0M | 162 | 100.0% |
VENUS PHARMA GMBH sources Meropenem from 1 verified Indian supplier based on 162 customs records. The primary supplier is VENUS REMEDIES LIMITED accounting for 100.0% of imports.
How Does VENUS PHARMA GMBH Compare to Nearest Meropenem Importers?
Buyers ranked immediately above and below #4 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | VENUS PHARMA GMBH ★ | GERMANY | $7.2M | 144 | $50.0K |
| 1 | YUSEN LOGISTICS BENELUX BELGIUM | BELGIUM | $7.2M | 143 | $50.0K |
| 7 | S T C | SAUDI ARABIA | $4.4M | 95 | $46.2K |
VENUS PHARMA GMBH ranks #4 among 966 Meropenem importers from India. Average shipment value of $50.0K compared to the market average of $38.7K. The closest competitors by value are YUSEN LOGISTICS BENELUX BELGIUM and S T C.
Where Does VENUS PHARMA GMBH Import Meropenem To?
Destination countries from 162 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| GERMANY | $3.0M | 162 | 100.0% |
VENUS PHARMA GMBH imports Meropenem to 1 country. The primary destination is GERMANY receiving 100.0% of shipments worth $3.0M.
What Meropenem Formulations Does VENUS PHARMA GMBH Import?
| Formulation | Value | Shipments |
|---|---|---|
| MEROPENEM 500 MG POWDER FOR SOLUTION FOR | $846.8K | 18 |
| MEROPENEM 1.0 GM POWDER FOR SOLUTION FOR | $755.4K | 18 |
| MEROPENEM 1.0GM POWDER FOR SOLUTION FOR | $200.0K | 4 |
| MEROPENEM 1.0 GM POWDER FOR SOLUTION FORINJECTION OR INFUSION MEROPENEM VENUSPHARMA 1.0 GM | $150.0K | 3 |
| MEROPENEM 1.0 GM POWDER FOR SOLUTION FORINJECTION OR INFUSION MEROPENEM ENEXI1000MG | $131.0K | 4 |
| MEROPENEM 500 MG POWDER FOR SOLUTION FORINJECTION OR INFUSION MEROPENEM VENUSPHARMA 500 MG | $99.6K | 2 |
| MEROPENEM 500MG POWDER FOR SOLUTION FOR | $56.1K | 4 |
| MEROPENEM 1 0 GM POWDER FOR SOLUTION FORINJECTION OR INFUSTION MEROPENEM VENUSPHARMA 1 0 GM | $50.0K | 1 |
| MEROPENEM 500 MG POWDER FOR SOLUTION FORINJECTION OR INFUSIION MEROPENEM VENUS PHARMA 500MG | $50.0K | 1 |
| MEROPENEM 1 0 GM POWDER FOR SOLUTION FORINJECTION OR INFUSION MEROPENEM VENUSPHARMA 1 G | $50.0K | 1 |
VENUS PHARMA GMBH imports 59 distinct Meropenem formulations from India. The top formulation is MEROPENEM 500 MG POWDER FOR SOLUTION FOR with 18 shipments worth $846.8K.
Regulatory Requirements: Importing Meropenem into Germany
What VENUS PHARMA GMBH and other importers must comply with to import Meropenem from India
Regulatory Authority
Federal Institute for Drugs and Medical Devices (BfArM) / European Medicines Agency (EMA) (BfArM/EMA)
Approval Process for Generic Meropenem
Marketing Authorisation Application (MAA) under EU Directive 2001/83/EC. Decentralized or Mutual Recognition Procedure for generics. Requires CTD Module 1–5 dossier.
Typical timeline: 12–18 months via Decentralized Procedure
GMP Requirements
EU GMP (EudraLex Vol. 4) compliance; GMP certificate issued by competent authority; WHO Prequalification accepted as supporting evidence
Import Licence & Documentation
Wholesale Distribution Authorisation (WDA) and Manufacturing/Import Authorisation (MIA) required for importer. Qualified Person (QP) must certify each batch.
Labeling & Packaging
EU labeling per Directive 2001/83/EC; German language patient leaflet (PIL) mandatory; serialization under EU Falsified Medicines Directive (FMD)
Note: EU FMD serialization and tamper-evident packaging mandatory since February 2019. Indian API/FDF manufacturers must hold EU GMP certificate.
Regulatory information is provided for general reference based on publicly available BfArM/EMA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with BfArM/EMA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Meropenem from India and How Much Does VENUS PHARMA GMBH Import?
India exported $37.3M worth of Meropenem through 3,658 shipments from 401 suppliers to 134 countries, serving 966 buyers globally. VENUS PHARMA GMBH imports $3.0M of this total, accounting for 4.4% of India's Meropenem exports with 162 shipments from GERMANY. This is verified from 162 customs shipment records covering 59 distinct formulations.
What Is the Average Order Value for VENUS PHARMA GMBH's Meropenem Imports?
VENUS PHARMA GMBH's average Meropenem order value is $18.7K per consignment, based on 162 shipments totaling $3.0M. VENUS PHARMA GMBH is based in GERMANY and ranks #4 among all Meropenem importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Meropenem to VENUS PHARMA GMBH?
VENUS PHARMA GMBH sources Meropenem from 1 verified Indian supplier: VENUS REMEDIES LIMITED ($3.0M, 100.0%). This is based on 162 customs records.
How Does VENUS PHARMA GMBH Compare to Other Meropenem Importers?
VENUS PHARMA GMBH ranks #4 among 966 Meropenem importers from India with a 4.4% market share. The top 3 importers are VENUS PHARMA GMBH ($7.2M), YUSEN LOGISTICS BENELUX BELGIUM ($7.2M), S T C ($4.4M). VENUS PHARMA GMBH processed 162 shipments from GERMANY.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Meropenem — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Meropenem shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: VENUS PHARMA GMBH matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as VENUS PHARMA GMBH's capped import value divided by total capped export value for Meropenem across all Indian exporters.
- 5.Verified Records: This page is backed by 162 individual customs records matching VENUS PHARMA GMBH importing Meropenem, covering 59 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 134+ countries, 966+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Meropenem Import Data for VENUS PHARMA GMBH
Access order-level details, pricing data, supplier connections, and competitive analysis for VENUS PHARMA GMBH's Meropenem imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
VENUS PHARMA GMBH
Company Profile
Multiple products · $0 total trade · Multiple categories
VENUS PHARMA GMBH × Meropenem
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for VENUS PHARMA GMBH.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Meropenem. For current order-level data, contact TransData Nexus.